Form 4: Elanco Animal Health Executive Todd S. Young Reports Changes in Beneficial Ownership

Todd S. Young, Executive Vice President and CFO of Elanco Animal Health, reports acquisition and disposal of company stock, resulting in adjusted beneficial ownership.

Summary

• On February 19, 2025, Todd S. Young, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc., reported changes in his beneficial ownership of the company's stock.
• Young acquired 104,930 shares of common stock at $0 and disposed of 46,045 shares at $11.24.
• Following these transactions, Young directly owns 159,062 shares of Elanco Animal Health Inc.
• Young also has indirect ownership through an IRA (6,562 shares), J.G. Young IRA (2,000 shares), a Living Trust (149,308 shares), and UTMA accounts for his daughter and son (3,500 shares each).

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral. It simply reports transactions and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their transactions in company stock. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in the financial industry.
• Similar filings are made by executives at companies like Zoetis and Merck Animal Health, allowing investors to compare executive stock ownership and trading activity across the animal health sector.
• Analyzing the ratio of stock acquisitions to disposals can provide insights into an executive's confidence in the company's future performance, relative to peers.

Stakeholder Impact

• Shareholders may be interested in the trading activity of key executives as an indicator of company performance expectations.
• The filing itself has minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elanco Animal Health, Todd S. Young, Beneficial Ownership, Stock Transactions, Form 4, Securities Exchange Act, Executive Compensation, Insider Trading